|Jmol-3D images||Image 1
|Molar mass||278.43 g mol−1|
| (what is: / ?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
α-Linolenic acid (ALA) is an organic compound found in many common vegetable oils. In terms of its structure, it is named all-cis-9,12,15-octadecatrienoic acid. In physiological literature, it is given the name 18:3 (n−3).
α-Linolenic acid is a carboxylic acid with an 18-carbon chain and three cis double bonds. The first double bond is located at the third carbon from the methyl end of the fatty acid chain, known as the n end. Thus, α-linolenic acid is a polyunsaturated n−3 (omega-3) fatty acid. It is an isomer of gamma-linolenic acid, a polyunsaturated n−6 (omega-6) fatty acid.
Alpha-linolenic acid was first isolated by Rollett as cited in J. W. McCutcheon's synthesis in 1942, and referred to in Green and Hilditch's 1930's survey. It was first artificially synthesized in 1995 from C6 homologating agents. A Wittig reaction of the phosphonium salt of [(Z-Z)-nona-3,6-dien-1-yl]triphenylphosphonium bromide with methyl 9-oxononanoate, followed by saponification, completed the synthesis.
Dietary sources 
Seed oils are the richest sources of α-linolenic acid, notably those of chia, perilla, flaxseed (linseed oil), rapeseed (canola), and soybeans. Alpha-Linolenic acid is also obtained from the thylakoid membranes in the leaves of Pisum sativum (pea leaves). ALA is not suitable for baking, as it will polymerize with itself, a feature exploited in paint with transition metal catalysts. Some ALA will also oxidize at baking temperatures. %ALA in the table below is for the oil extracted from each item.
|Common name||Alternate name||Linnaean name||% ALA†||ref.|
|Chia||chia sage||Salvia hispanica||64%|||
|Kiwifruit seeds||Chinese gooseberry||Actinidia chinensis||62%|||
|Sea buckthorn||seaberry||Hippophae rhamnoides L.||32%|||
Potential role in nutrition and health 
α-Linolenic acid, an n−3 fatty acid, is a member of the group of essential fatty acids (EFAs), so called because they cannot be produced within the body and must be acquired through diet. Most seeds and seed oils are much richer in an n−6 fatty acid, linoleic acid. Linoleic acid is also an EFA, but it, and the other n−6 fatty acids, compete with n−3s for positions in cell membranes and have very different effects on human health. (See Essential fatty acid interactions.)
α-Linolenic acid can only be obtained by humans through their diets because the absence of the required 12- and 15-desaturase enzymes makes de novo synthesis from stearic acid impossible. Eicosapentaenoic acid (EPA; 20:5, n−3) and docosahexaenoic acid (DHA; 22:6, n−3) are readily available from fish and algae oil and play a vital role in many metabolic processes. These can also be synthesized by humans from dietary α-linolenic acid, but with an efficiency of only a few percent. Because the efficacy of n−3 long-chain polyunsaturated fatty acid (LC-PUFA) synthesis decreases down the cascade of α-linolenic acid conversion, DHA synthesis from α-linolenic acid is even more restricted than that of EPA.
A 2005 study found that daily administration of α-linolenic acid significantly reduced both self-reported anxiety, stress levels, and objective measured cortisol levels in college age students.
A large 2006 study found no association between total α-linolenic acid intake and overall risk of prostate cancer. Multiple studies have shown a relationship between alpha-linolenic acid (ALA), which is abundant in linseed oil, and an increased risk of prostate cancer. This risk was found to be irrespective of source of origin (e.g., meat, vegetable oil). A recent (2009) meta-analysis, however, found evidence of publication bias in earlier studies, and concluded that if ALA contributes to increased prostate cancer risk, the increase in risk is quite small. In contrast, alpha-linoleic acid was recently shown to negatively regulate the growth of cancer cells, but not healthy cells, in vitro.
Basic research has also suggested a major neuroprotective effect of α-linolenic acid in in vivo models of both global ischemia and kainate-induced epilepsy; however, if sourced from flax seed oil, residues may have adverse effect due to its content of neurotoxic cyanogen glycosides and immunosuppressive cyclic nonapeptides.
A 2011 longitudinal study of over 50,000 women, conducted at Harvard University, over a period of ten years, found that a higher intake of α-linolenic acid (combined with a lower intake of linoleic acid) was positively associated with a significant reduction in depression in the same group (the same study also found that by contrast an intake of EPA and DHA found in fish oils did not reduce depression).
Stability and Hydrogenation 
Alpha-linolenic acid is relatively more susceptible to oxidation and will become rancid more quickly than many other oils. Oxidative instability of α-linolenic acid is one reason why producers choose to partially hydrogenate oils containing α-linolenic acid, such as soybean oil. Soybeans are the largest source of edible oils in the U.S., and 40% of soy oil production is partially hydrogenated.
However, when partially hydrogenated, part of the unsaturated fatty acids become unhealthy trans fats. Consumers are increasingly avoiding products that contain trans fats, and governments have begun to ban trans fats in food products. These regulations and market pressures have spurred the development of low-α-linolenic acid soybeans. These new soybean varieties yield a more stable oil that doesn't require hydrogenation for many applications, thus providing trans fat-free products, such as frying oil.
Several consortia are bringing low-α-linolenic acid soy to market. DuPont's effort involves silencing the FAD2 gene that codes for Δ6-desaturase, giving a soy oil with very low levels of both α-linolenic acid and linoleic acid. Monsanto Company has introduced to the market Vistive, their brand of low α-linolenic acid soybeans, which is less controversial than GMO offerings, as it was created via conventional breeding techniques.
Dietary α-linolenic acid has been assessed for its role in cardiovascular health. Clinical benefits have been seen in some, but not all, studies. Still, a review in 2005 concluded "The weight of the evidence favors recommendations for modest dietary consumption of α-linolenic acid (2 to 3 g per day) for the primary and secondary prevention of coronary heart disease."
See also 
- Loreau, O; Maret, A; Poullain, D; Chardigny, JM; Sébédio, JL; Beaufrère, B; Noël, JP (2000). "Large-scale preparation of (9Z,12E)-1-(13)C-octadeca-9,12-dienoic acid, (9Z,12Z,15E)-1-(13)C-octadeca-9,12,15-trienoic acid and their 1-(13)C all-cis isomers". Chemistry and physics of lipids 106 (1): 65–78. doi:10.1016/S0009-3084(00)00137-7. PMID 10878236.
- Beare-Rogers (2001). "IUPAC Lexicon of Lipid Nutrition" (pdf). Archived from the original on 12 February 2006. Retrieved 22 February 2006.
- Rollett, A. (1909). "Zur kenntnis der linolensäure und des leinöls". Z. Physiol. Chem. 62 (5–6): 422. doi:10.1515/bchm2.1909.62.5-6.422.
- J. W. McCutcheon (1955), "Linolenic acid", Org. Synth.; Coll. Vol. 3: 351
- Green, TG; Hilditch, TP (1935). "The identification of linoleic and linolenic acids". Biochem. J. 29 (7): 1552–63. PMC 1266662. PMID 16745822.
- Sandri, J.; Viala, J. (1995). "Direct preparation of (Z,Z)-1,4-dienic units with a new C6 homologating agent: synthesis of alpha-linolenic acid". Synthesis 3 (3): 271–275. doi:10.1055/s-1995-3906.
- Chapman, David J.; De-Felice, John and Barber, James (May 1983). "Growth temperature effects on thylakoid membrane lipid and protein content of pea chloroplasts 1". Plant Physiol 72 (1): 225–228. doi:10.1104/pp.72.1.225. PMC 1066200. PMID 16662966.
- "OXIDATIVE STABILITY OF FLAXSEED LIPIDS DURING BAKING".
- Seed Oil Fatty Acids – SOFA Database Retrieval
- Li, Thomas S. C. (1999). "Sea buckthorn: New crop opportunity". Perspectives on new crops and new uses. Alexandria, VA: ASHS Press. pp. 335–337. Archived from the original on 22 September 2006. Retrieved 2006-10-28.
- Breanne M Anderson and David WL Ma (2009). "Are all n-3 polyunsaturated fatty acids created equal?". Lipids in Health and Disease 8 (33): 33. doi:10.1186/1476-511X-8-33.
- Shiels M. Innis (2007). "Fatty acids and early human development". Early Human Development 83 (12): 761–766. doi:10.1016/j.earlhumdev.2007.09.004. PMID 17920214.
- Burdge, GC; Calder, PC (2005). "Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults". Reproduction, nutrition, development 45 (5): 581–97. doi:10.1051/rnd:2005047. PMID 16188209.
- Penny M. Kris-Etherton, William S. Harris, [and] Lawrence J. Appel, for the Nutrition Committee (2002). "Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease". Circulation 106 (21): 2747–2757. doi:10.1161/01.CIR.0000038493.65177.94. PMID 12438303.
- William E. Connor (2000). "Importance of n−3 fatty acids in health and disease". American Journal of Clinical Nutrition 71 (1 Suppl.): 171S–175S. PMID 10617967. Unknown parameter
- Yehuda S., Rabinovitz S., Mostofsky D.I. (2005). "Mixture of essential fatty acids lowers test anxiety". Nutritional Neuroscience 8 (4): 265–267. doi:10.1080/10284150500445795. PMID 16491653.
- Koralek DO, Peters U, Andriole G, et al. (2006). "A prospective study of dietary α-linolenic acid and the risk of prostate cancer (United States)". Cancer Causes Control 17 (6): 783–791. doi:10.1007/s10552-006-0014-x. PMID 16783606.
- Ramon, JM; Bou, R; Romea, S; Alkiza, ME; Jacas, M; Ribes, J; Oromi, J (2000). "Dietary fat intake and prostate cancer risk: a case-control study in Spain". Cancer causes & control : CCC 11 (8): 679–85. doi:10.1023/A:1008924116552. PMID 11065004.
- Brouwer, IA; Katan, MB; Zock, PL (2004). "Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis". The Journal of nutrition 134 (4): 919–22. PMID 15051847.
- De Stéfani, E; Deneo-Pellegrini, H; Boffetta, P; Ronco, A; Mendilaharsu, M (2000). "Alpha-linolenic acid and risk of prostate cancer: a case-control study in Uruguay". Cancer Epidemiology, Biomarkers & Prevention 9 (3): 335–8. PMID 10750674.
- Simon, JA; Chen, YH; Bent, S (2009). "The relation of alpha-linolenic acid to the risk of prostate cancer". American Journal of Clinical Nutrition 89 (5): 1558S–1564S. doi:10.3945/ajcn.2009.26736E. PMID 19321563.
- Deshpande, R; Mansara, P; Suryavanshi, S; Kaul-Ghanekar, R (2013). "Alpha-linolenic acid regulates the growth of breast and cervical cancer cell lines through regulation of NO release and induction of lipid peroxidation". Journal of Molecular Biochemistry 2 (1): 6–17.
- Inger Lauritzen, Nicolas Blondeau, Catherine Heurteaux, Catherine Widmann, Georges Romey and Michel Lazdunski (2000). "Polyunsaturated fatty acids are potent neuroprotectors". The EMBO Journal 19 (8): 1784–1793. doi:10.1093/emboj/19.8.1784. PMC 302016. PMID 10775263.
- , "WO 2006137717 Edible flaxseed oil which saturated fatty acid and toxic components were removed therefrom and preparative process thereof"
- M. Lucas, F. Mirzaei, E. J. O'Reilly, A. Pan, W. C. Willett, I. Kawachi, K. Koenen, and A. Ascherio (2011). "Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study". Am J Clin Nutr 93 (6): 1337–43. doi:10.3945/ajcn.111.011817. PMC 3095504. PMID 21471279.
- Kinney, Tony. "Metabolism in plants to produce healthier food oils (slide #4)" (PDF). Retrieved 2007-01-11.
- Fitzgerald, Anne and Brasher, Philip. "Ban on trans fat could benefit Iowa". Truth About Trade and Technology. Retrieved 2007-01-03.[dead link]
- Kinney, Tony. "Metabolism in plants to produce healthier food oils (slide #2)" (PDF). Retrieved 2007-01-11.
- Monsanto. "ADM to process Monsanto's Vistive low linolenic soybeans at Indiana facility". Archived from the original on 2006-12-11. Retrieved 2007-01-06.
- Kinney, Tony. "Metabolism in plants to produce healthier food oils" (PDF). Retrieved 2007-01-11.
- Mozaffarian D (2005). "Does α-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence". Alternative therapies in health and medicine 11 (3): 24–30; quiz 31, 79. PMID 15945135.